Santhera Pharmaceuticals Holding AG
(FRA:S3F0)
€
136.4
0 (0%)
Market Cap: 115.85 Mil
Enterprise Value: 157.24 Mil
PE Ratio: 1.75
PB Ratio: 1.66
GF Score: 40/100 Santhera Pharmaceuticals Holding AG (FRA:S3F0) Transcripts
- Full Year 2023 Santhera Pharmaceuticals Holding AG Earnings Call TranscriptApr 25, 2024Earnings
- Santhera Pharmaceuticals Holding AG at HC Wainwright Investment Conference - New York TranscriptSep 12, 2023
- Santhera Pharmaceuticals Holding AG To Discuss The Agreement on Vamorolone TranscriptJun 20, 2023
- Full Year 2022 Santhera Pharmaceuticals Holding AG Earnings Call TranscriptApr 27, 2023€136.4Earnings
- Half Year 2022 Santhera Pharmaceuticals Holding AG Earnings Call TranscriptNov 07, 2022€136.4Earnings
- Full Year 2021 Santhera Pharmaceuticals Holding AG Earnings Call TranscriptJun 10, 2022€136.4Earnings
- Santhera Pharmaceuticals Holding AG Investor Conference Call - Looking Ahead to 2022 TranscriptDec 08, 2021
- Q2 2021 Santhera Pharmaceuticals Holding AG Earnings Call TranscriptSep 22, 2021€136.4Earnings
- Q4 2020 Santhera Pharmaceuticals Holding AG Earnings Call TranscriptApr 29, 2021€136.4Earnings
- 1